BMO Capital initiated coverage of Addus HomeCare (ADUS) with a Market Perform rating and $120 price target The firm says it will look to get more constructive on the shares when concerns around Medicaid funding cuts start to ease. It remains positive on the longer-term macro shift toward in-home care, and Addus HomeCare’s positioning.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADUS:
- Addus HomeCare price target raised to $139 from $134 at RBC Capital
- Addus HomeCare price target raised to $140 from $139 at TD Cowen
- Addus HomeCare Reports Strong Q3 2025 Results
- Addus Homecare: Strategic Growth and Strong Financial Performance Justify Buy Rating
- Addus HomeCare Q3 2025 Earnings: Growth Amid Challenges